Dopamine D2 receptor plays a role in memory function: implications of dopamine-acetylcholine interaction in the ventral hippocampus. 2005

Hiroshige Fujishiro, and Hiroyuki Umegaki, and Yusuke Suzuki, and Shinobu Oohara-Kurotani, and Yoko Yamaguchi, and Akihisa Iguchi
Department of Geriatrics, Medicine in Growth and Aging, Program in Health and Community Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Nagoya, Aichi, 466-8550, Japan.

BACKGROUND The role of the hippocampal dopaminergic system in mnemonic function has not been clarified yet. OBJECTIVE We previously reported that the dopamine D2 receptor (D2R) is involved in the regulation of acethylcholin (ACh) release in the hippocampus. In this study, we further investigated ACh-dopamine (DA) interaction in the hippocampus and its involvement in mnemonic function. METHODS For experiment 1, rats fed with Cholin (Ch)-deficient chow were used. We examined the effects of D2R antagonist, raclopride, on cognitive performance using a passive avoidance task. We further carried out in vivo microdialysis to assess the effect of infusion of D2R agonist, quinpirole, into the ventral hippocampus on its capacity to release ACh. For experiment 2, rats fed with normal chow were used. The performance of a radial arm maze task was assessed to examine the effects of hippocampal injection of D2R agonist, quinpirole, on memory impairment induced by scopolamine, a muscarinic ACh antagonist. RESULTS In experiment 1, rats fed with Ch-deficient chow showed impaired performances indicated by prolonged latency on retention trials of a passive avoidance task following the hippocampal injection of D2R antagonist, and showed reduced capacity to release ACh following the injection of D2R agonist compared with rats fed with normal chow. In experiment 2, memory impairment induced by the intraperitoneal injection of scopolamine was ameliorated by the injection of D2R agonist into the ventral hippocampus. CONCLUSIONS These results indicate the possible involvement of hippocampal ACh-DA interaction in mnemonic processing.

UI MeSH Term Description Entries
D008297 Male Males
D008568 Memory Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000109 Acetylcholine A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. 2-(Acetyloxy)-N,N,N-trimethylethanaminium,Acetilcolina Cusi,Acetylcholine Bromide,Acetylcholine Chloride,Acetylcholine Fluoride,Acetylcholine Hydroxide,Acetylcholine Iodide,Acetylcholine L-Tartrate,Acetylcholine Perchlorate,Acetylcholine Picrate,Acetylcholine Picrate (1:1),Acetylcholine Sulfate (1:1),Bromoacetylcholine,Chloroacetylcholine,Miochol,Acetylcholine L Tartrate,Bromide, Acetylcholine,Cusi, Acetilcolina,Fluoride, Acetylcholine,Hydroxide, Acetylcholine,Iodide, Acetylcholine,L-Tartrate, Acetylcholine,Perchlorate, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001362 Avoidance Learning A response to a cue that is instrumental in avoiding a noxious experience. Aversion Behavior,Aversion Learning,Aversive Behavior,Aversive Learning,Avoidance Behavior,Aversion Behaviors,Aversive Behaviors,Avoidance Behaviors,Behavior, Aversion,Behavior, Aversive,Behavior, Avoidance,Behaviors, Aversion,Behaviors, Aversive,Behaviors, Avoidance,Learning, Aversion,Learning, Aversive,Learning, Avoidance
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2
D017551 Microdialysis A technique for measuring extracellular concentrations of substances in tissues, usually in vivo, by means of a small probe equipped with a semipermeable membrane. Substances may also be introduced into the extracellular space through the membrane.

Related Publications

Hiroshige Fujishiro, and Hiroyuki Umegaki, and Yusuke Suzuki, and Shinobu Oohara-Kurotani, and Yoko Yamaguchi, and Akihisa Iguchi
August 2008, Molecular pharmacology,
Hiroshige Fujishiro, and Hiroyuki Umegaki, and Yusuke Suzuki, and Shinobu Oohara-Kurotani, and Yoko Yamaguchi, and Akihisa Iguchi
October 2016, Behavioural brain research,
Hiroshige Fujishiro, and Hiroyuki Umegaki, and Yusuke Suzuki, and Shinobu Oohara-Kurotani, and Yoko Yamaguchi, and Akihisa Iguchi
October 2004, Brain research,
Hiroshige Fujishiro, and Hiroyuki Umegaki, and Yusuke Suzuki, and Shinobu Oohara-Kurotani, and Yoko Yamaguchi, and Akihisa Iguchi
January 2020, Frontiers in pharmacology,
Hiroshige Fujishiro, and Hiroyuki Umegaki, and Yusuke Suzuki, and Shinobu Oohara-Kurotani, and Yoko Yamaguchi, and Akihisa Iguchi
August 2021, Molecular pharmacology,
Hiroshige Fujishiro, and Hiroyuki Umegaki, and Yusuke Suzuki, and Shinobu Oohara-Kurotani, and Yoko Yamaguchi, and Akihisa Iguchi
January 2022, Frontiers in pharmacology,
Hiroshige Fujishiro, and Hiroyuki Umegaki, and Yusuke Suzuki, and Shinobu Oohara-Kurotani, and Yoko Yamaguchi, and Akihisa Iguchi
January 2017, Cannabis and cannabinoid research,
Hiroshige Fujishiro, and Hiroyuki Umegaki, and Yusuke Suzuki, and Shinobu Oohara-Kurotani, and Yoko Yamaguchi, and Akihisa Iguchi
June 1991, The Japanese journal of psychiatry and neurology,
Hiroshige Fujishiro, and Hiroyuki Umegaki, and Yusuke Suzuki, and Shinobu Oohara-Kurotani, and Yoko Yamaguchi, and Akihisa Iguchi
February 1996, Genes to cells : devoted to molecular & cellular mechanisms,
Hiroshige Fujishiro, and Hiroyuki Umegaki, and Yusuke Suzuki, and Shinobu Oohara-Kurotani, and Yoko Yamaguchi, and Akihisa Iguchi
September 1990, European journal of pharmacology,
Copied contents to your clipboard!